Antioxidant Status, Lipid Peroxidation and Nitric Oxide in Fibromyalgia: Etiologic and Therapeutic Concerns

Overview

Journal Rheumatol Int

Specialty Rheumatology

Date 2005 Nov 12

PMID 16283318

Citations 37

Authors

Salih Ozgocmen

Huseyin Ozyurt

Sadik Sogut

Omer Akyol

Ozge Ardicoglu

Hulya Yildizhan

Affiliations

Soon will be listed here.

Abstract

We proposed to assess the oxidant/antioxidant status, lipid peroxidation and nitric oxide (NO) in untreated fibromyalgia (FM) patients and controls. The effect of amitriptyline (A, 20 mg daily) and sertraline (S, 100 mg daily) treatment on patients' superoxide dismutase (SOD), xanthine oxidase (XO), adenosine deaminase (ADA) enzyme activities, thiobarbituric acid reactive substances (TBARS) and NO levels was investigated. Thirty female patients with primary FM and age-matched 16 healthy female controls were included. Patients received an 8-week course of treatment with either A or S. FM patients had higher serum levels of TBARS (particularly malondialdehyde) and lower levels of nitrite compared to controls whereas enzyme activities were similar. A and S significantly improved Fibromyalgia Impact Questionnaire (FIQ) pain scores, Hamilton anxiety and depression rating scales. But neither A nor S had significant effects on measured oxidative stress parameters, except SOD activity that was significantly reduced after S treatment. Total myalgic scores negatively correlated with XO activity, and depression scales negatively correlated with levels of TBARS. Our results indicate that patients with FM are under oxidative stress. These findings represent a rationale for further research assessing the effect of free radical scavengers or antioxidant agents like vitamins and omega-3 fatty acids on peripheral and central mechanisms in FM.

Citing Articles

Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome.

Pihtili Tas N, Baykara R, Kamanli A, Gurbuz A, Cure E, Cumhur Cure M Arch Rheumatol. 2024; 39(3):375-383.

PMID: 39507838 PMC: 11537681. DOI: 10.46497/ArchRheumatol.2024.10462.

Nutraceutical Supplementation as a Potential Non-Drug Treatment for Fibromyalgia: Effects on Lipid Profile, Oxidative Status, and Quality of Life.

de la Cruz Cazorla S, Blanco S, Rus A, Molina-Ortega F, Ocana E, Hernandez R Int J Mol Sci. 2024; 25(18).

PMID: 39337423 PMC: 11432491. DOI: 10.3390/ijms25189935.

Proteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies.

Gkouvi A, Tsiogkas S, Bogdanos D, Gika H, Goulis D, Grammatikopoulou M Curr Pain Headache Rep. 2024; 28(7):565-586.

PMID: 38652420 PMC: 11271354. DOI: 10.1007/s11916-024-01244-4.

Melatonin as a Coadjuvant in the Treatment of Patients with Fibromyalgia.

Gonzalez-Flores D, Lopez-Pingarron L, Castano M, Gomez M, Rodriguez A, Garcia J Biomedicines. 2023; 11(7).

PMID: 37509603 PMC: 10377739. DOI: 10.3390/biomedicines11071964.

Long Term Treatment of Corticostreroids May Cause Hepatotoxicity and Oxidative Damage: A Case Controlled Study.

Tiwari P, Singh N, Sharma B Indian J Clin Biochem. 2023; :1-9.

PMID: 37360645 PMC: 10066027. DOI: 10.1007/s12291-023-01127-2.

References

Ozgocmen S, Catal S, Ardicoglu O, Kamanli A . Effect of omega-3 fatty acids in the management of fibromyalgia syndrome. Int J Clin Pharmacol Ther. 2000; 38(7):362-3. DOI: 10.5414/cpp38362. View

Sun Y, Oberley L, Li Y . A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988; 34(3):497-500. View

Hein G, Franke S . Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?. Rheumatology (Oxford). 2002; 41(10):1163-7. DOI: 10.1093/rheumatology/41.10.1163. View

Cepinskas G, Rui T, Kvietys P . Interaction between reactive oxygen metabolites and nitric oxide in oxidant tolerance. Free Radic Biol Med. 2002; 33(4):433-40. DOI: 10.1016/s0891-5849(02)00962-0. View

Hostmark A, Lystad E, VELLAR O, Hovi K, Berg J . Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet. Plant Foods Hum Nutr. 1993; 43(1):55-61. DOI: 10.1007/BF01088096. View

Manuel y Keenoy B, Moorkens G, Vertommen J, De Leeuw I . Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci. 2001; 68(17):2037-49. DOI: 10.1016/s0024-3205(01)01001-3. View

Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T . Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett. 2003; 335(3):151-4. DOI: 10.1016/s0304-3940(02)01058-3. View

Cortas N, Wakid N . Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem. 1990; 36(8 Pt 1):1440-3. View

Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O . Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int. 2003; 24(2):80-3. DOI: 10.1007/s00296-003-0335-y. View

10.

Crofford L, Appleton B . The treatment of fibromyalgia: a review of clinical trials. Curr Rheumatol Rep. 2000; 2(2):101-3. DOI: 10.1007/s11926-000-0048-0. View

11.

Lund N, Bengtsson A, Thorborg P . Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol. 1986; 15(2):165-73. DOI: 10.3109/03009748609102084. View

12.

Kingwell B . Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. FASEB J. 2000; 14(12):1685-96. DOI: 10.1096/fj.99-0896rev. View

13.

Esterbauer H, Schaur R, Zollner H . Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991; 11(1):81-128. DOI: 10.1016/0891-5849(91)90192-6. View

14.

Bennett R, Clark S, Goldberg L, Nelson D, Bonafede R, Porter J . Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum. 1989; 32(4):454-60. DOI: 10.1002/anr.1780320415. View

15.

Okifuji A, Turk D, Sinclair J, Starz T, Marcus D . A standardized manual tender point survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol. 1997; 24(2):377-83. View

16.

Jeschonneck M, Grohmann G, Hein G, Sprott H . Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology (Oxford). 2000; 39(8):917-21. DOI: 10.1093/rheumatology/39.8.917. View

17.

Goldenberg D . Fibromyalgia syndrome a decade later: what have we learned?. Arch Intern Med. 1999; 159(8):777-85. DOI: 10.1001/archinte.159.8.777. View

18.

Hamilton M . The assessment of anxiety states by rating. Br J Med Psychol. 1959; 32(1):50-5. DOI: 10.1111/j.2044-8341.1959.tb00467.x. View

19.

Bilici M, Efe H, Koroglu M, Uydu H, BEKAROGLU M, Deger O . Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001; 64(1):43-51. DOI: 10.1016/s0165-0327(00)00199-3. View

20.

Lindh M, Johansson G, Hedberg M, Henning G, Grimby G . Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol. 1995; 24(1):34-7. DOI: 10.3109/03009749509095152. View